Muscle wasting induced by HTLV-1 Tax-1 protein: An in vitro and in vivo study

American Journal of Pathology

Volumn 167, Issue 6, 2005, Pages 1609-1619

  Ozden, Simona ^a   Mouly, Vincent ^b   Prevost, Marie Christine ^a   Gessain, Antoine ^a   Butler Browne, Gillian ^b   Ceccaldi, Pierre Emmanuel ^a  

^a INSTITUT PASTEUR   (France)

^b CNRS   (France)

Author keywords

[No Author keywords available]

Indexed keywords

DESMIN; PROTEIN TAX 1; TAX PROTEIN; UNCLASSIFIED DRUG; VIMENTIN; VIRUS VECTOR;

ARTICLE; CELL DIFFERENTIATION; CONTROLLED STUDY; CYTOTOXICITY; DISEASE ASSOCIATION; GENE; HUMAN; HUMAN CELL; HUMAN T CELL LEUKEMIA VIRUS 1; HUMAN TISSUE; IN VITRO STUDY; INFLAMMATION; LENTIVIRINAE; MUSCLE ATROPHY; MUSCLE BIOPSY; MUSCLE CELL; MYOSITIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INDUCTION; REPRODUCIBILITY; SIGNAL TRANSDUCTION; SPASTIC PARAPLEGIA; SPINAL CORD DISEASE; TAX GENE;

EID: 28244465116     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9440(10)61245-X     Document Type: Article

References (59)

1. Figarella-Branger D, Civatte M, Bartoli C, Pellissier JF: Cytokines, chemokines, and cell adhesion molecules in inflammatory myopathies. Muscle Nerve 2003, 28:659-682
2. Mastaglia FL, Garlepp MJ, Phillips BA, Zilko PJ: Inflammatory myopathies: clinical, diagnostic and therapeutic aspects. Muscle Nerve 2003, 27:407-425
3. Dalakas MC: Retroviruses and inflammatory myopathies in humans and primates. Baillieres Clin Neurol 1993, 2:659-691
4. Poiesz B, Ruscetti F, Gazdar A, Bunn P, Minna J, Gallo RC: Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T cell lymphoma. Proc Natl Acad Sci USA 1980, 77:7415-7419
5. Gessain A, Barin F, Vernant JC, Gout O, Maurs L, Calender A, de The G: Antibodies to human T-lymphotropic virus type-I in patients with tropical spastic paraparesis. Lancet 1985, 2:407-410
6. Gilbert DT, Morgan O, Smikle MF, Simeon D, Barton EN: HTLV-1 associated polymyositis in Jamaica. Acta Neurol Scand 2001, 104:101-104
7. Sherman MP, Amin RM, Rodgers-Johnson PE, Morgan OS, Char G, Mora CA, Iannone R, Collins GH, Papsidero L, Gibbs Jr CJ, Poiesz BJ: Identification of human T cell leukemia/lymphoma virus type I antibodies DNA, and protein in patients with polymyositis. Arthritis Rheum 1995, 38:690-698
8. Smadja D, Bellance R, Cabre P, Arfi S, Vernant JC: Clinical characteristics of HTLV-1 associated dermato-polymyositis. Seven cases from Martinique. Acta Neurol Scand 1995, 92:206-212
9. Caldwell CJ, Barrett WY, Breuer J, Farmer SF, Swash M: HTLV-1 polymyositis. Neuromuscul Disord 1996, 6:151-154
10. Higuchi I, Nerenberg M, Yoshimine K, Yoshida M, Fukunaga H, Tajima K, Osame M: Failure to detect HTLV-I by in situ hybridization in the biopsied muscles of viral carriers with polymyositis. Muscle Nerve 1992, 15:43-47
11. Higuchi I, Hashimoto K, Kashio N, Izumo S, Inose M, Izumi K, Ohkubo R, Nakagawa M, Arimura K, Osame M: Detection of HTLV-I provirus by in situ polymerase chain reaction in mononuclear inflammatory cells in skeletal muscle of viral carriers with polymyositis. Muscle Nerve 1995, 18:854-858
12. Leon-Monzon M, Illa I, Dalakas MC: Polymyositis in patients infected with human T cell leukemia virus type I: the role of the virus in the cause of the disease. Ann Neurol 1994, 36:643-649
13. Ozden S, Gessain A, Gout O, Mikol J: Sporadic inclusion body myositis in a patient with human T cell leukemia virus type 1-associated myelopathy. Clin Infect Dis 2001, 32:510-514
14. Cupler EJ, Leon-Monzon M, Miller J, Semino-Mora C, Anderson TL, Dalakas MC: Inclusion body myositis in HIV-1 and HTLV-1 infected patients. Brain 1996, 119:1887-1893
15. Arnardottir S, Borg K, Ansved T: Sporadic inclusion body myositis: morphology, regeneration, and cytoskeletal structure of muscle fibers. J Neurol Neurosurg Psychiatry 2004, 75:917-920
16. Capetanaki Y, Milner DJ: Desmin cytoskeleton in muscle integrity and function. Subcell Biochem 1998, 31:463-495
17. Capetanaki Y, Milner DJ, Weitzer G: Desmin in muscle formation and maintenance: knockouts and consequences. Cell Struct Funct 1997, 22:103-116
18. Carlsson L, Thornell LE: Desmin-related myopathies in mice and man. Acta Physiol Scand 2001, 171:341-348
19. Galou M, Gao J, Humbert J, Mericskay M, Li Z, Paulin D, Vicart P: The importance of intermediate filaments in the adaptation of tissues to mechanical stress: evidence from gene knockout studies. Biol Cell 1997, 89:85-97
20. Decary S, Mouly V, Hamida CB, Sautet A, Barbet JP, Butler-Browne GS: Replicative potential and telomere length in human skeletal muscle: implications for satellite cell-mediated gene therapy. Hum Gene Ther 1997, 8:1429-1438
21. Miyoshi I, Kubonishi I, Yoshimoto S, Akagi T, Ohtsuki Y, Shiraishi Y, Nagata K, Hinuma Y: Type C virus particles in a cord T-cell line derived by co-cultivating normal human cord leukocytes and human leukaemic T cells. Nature 1981, 294: 770-771
22. Popovic M, Lange-Wantzin G, Sarin P, Mann D, Gallo RC: Transformation of human umbilical cord blood T cells by human T cell leukaemia:lymphoma virus. Proc Natl Acad Sci USA 1983, 80:5402-5406
23. Salahuddin SZ, Markham P, Wong-Staal F, Franchini G, Kalyanaraman V, Gallo RC: Restricted expression of human T cell leukemia-lymphoma virus (HTLV) in transformed human umbilical cord blood lymphocytes. Virology 1983, 129:51-64
24. Foley G, Lazarus H, Farber S, Uzman B, Boone B, McCarthy R: Continuous culture of human lymphoblasts from peripheral blood of a child with acute leukemia. Cancer 1965, 18:522-529
25. Schneider LJ, Schwenk HU, Bornkamm G: Characterization of EBV-genome negative "null" and "T" cell lines derived from children with acute lymphoblastic leukemia and leukemic transformed non-Hodgkin lymphoma. Int J Cancer 1977, 19:621-626
26. Romero IA, Prevost MC, Perret E, Adamson P, Greenwood J, Couraud PO, Ozden S: Interactions between brain endothelial cells and human T cell leukemia virus type 1-infected lymphocytes: mechanisms of viral entry into the central nervous system. J Virol 2000, 74:6021-6030
27. Royer-Leveau C, Mordelet E, Delebecque F, Gessain A, Chameau P, Ozden S: Efficient transfer of HTLV-1 tax gene in various primary and immortalized cells using a flap lentiviral vector. J Virol Methods 2002, 105:133-140
28. Ozden S, Cochet M, Mikol J, Teixeira A, Gessain A, Pique C: Direct evidence for a chronic CD8+-T cell-mediated immune reaction to Tax within the muscle of a human T cell leukemia/lymphoma virus type 1-infected patient with sporadic inclusion body myositis. J Virol 2004, 78:10320-10327
29. Morgan OS, Rodgers-Johnson P, Mora C, Char G: HTLV-1 and polymyositis in Jamaica. Lancet 1989, 2:1184-1187
30. Higuchi I, Hashimoto K, Matsuoka E, Rosales R, Nakagawa M, Arimura K, Izumo S, Osame M: The main HTLV-I-harboring cells in the muscles of viral carriers with polymyositis are not macrophages but CD4+ lymphocytes. Acta Neuropathol (Berl) 1996, 92:358-361
31. Higuchi I, Montemayor ES, Izumo S, Inose M, Osame M: Immunohistochemical characteristics of polymyositis in patients with HTLV-I-associated myelopathy and HTLV-I carriers. Muscle Nerve 1993, 16:472-476
32. Wiley CA, Nerenberg M, Cros D, Soto-Aguilar MC: HTLV-I polymyositis in a patient also infected with the human immunodeficiency virus. N Engl J Med 1989, 320:992-995
33. Douen AG, Pringle CE, Guberman A: Human T cell lymphotropic virus type 1 myositis, peripheral neuropathy, and cerebral white matter lesions in the absence of spastic paraparesis. Arch Neurol 1997, 54:896-900
34. Manel N, Kim FJ, Kinet S, Taylor N, Sitbon M, Battini JL: The ubiquitous glucose transporter GLUT-1 is a receptor for HTLV. Cell 2003, 115:449-459
35. Gaster M, Handberg A, Beck-Nielsen H, Schroder HD: Glucose transporter expression in human skeletal muscle fibers. Am J Physiol 2000, 279:E529-E538
36. Inose M, Higuchi I, Yoshimine K, Suehara M, Izumo S, Arimura K, Osame M: Pathological changes in skeletal muscle in HTLV-I-associated myelopathy. J Neurol Sci 1992, 110:73-78
37. Gabbai AA, Wiley CA, Oliveira AS, Smith R, Schmidt B, Nobrega JA, Bordin JO, Roman GC: Skeletal muscle involvement in tropical spastic paraparesis/HTLV-1-associated myelopathy. Muscle Nerve 1994, 17:923-930
38. Oliveira HA, Madeira JC, Fakhouri R: Polymyositis and HTLV-I infection: case report. Ar Qneuropsiquiatr 2000, 58:935-938
39. Scola RH, Werneck LC, Heinig ME, Milano JB, Almeida SM, Arruda WO: Inflammatory myopathy on HTLV-I infection: case report. Ar Qneuropsiquiatr 2001, 59:119-122
40. Shi Y: Mechanisms of caspase inhibition and activation during apoptosis. Mol Cell 2002, 9:459-470
41. Earnshaw WC, Martins L, Kaufmann SH: Mammalian caspases: structure, activation, substrates, and functions during apoptosis. Annu Rev Biochem 1999, 68:383-424
42. Li Z, Mericskay M, Agbulut O, Butler-Browne G, Carlsson L, Thornell LE, Babinet C, Paulin D: Desmin is essential for the tensile strength and integrity of myofibrils but not for myogenic commitment, differentiation, and fusion of skeletal muscle. J Cell Biol 1997, 139:129-144
43. Dalakas MC, Park KY, Semino-Mora C, Lee HS, Sivakumar K, Goldfarb LG: Desmin myopathy, a skeletal myopathy with cardiomyopathy caused by mutations in the desmin gene. N Engl J Med 2000, 342:770-780
44. Buckle GJ, Hafler DA, Höllsberg P: HTLV-I-induced T cell activation. J Acquir Immune Defic Syndr Hum Retrovirol 1996, 13:3107-3113
45. Saggioro D, Wang JM, Sironi M, Luini W, Mantovani A, Chieco-Bianchi L: Chemoattractant(s) in culture supernatants of HTLV-I-infected T cell lines. AIDS Res Hum Retroviruses 1991, 7:571-577
46. Lindholm PF, Reid RL, Brady JN: Extracellular Tax1 protein stimulates tumor necrosis factor-beta and immunoglobulin kappa light chain expression in lymphoid cells. J Virol 1992, 66:1294-1302
47. Lindholm PF, Marriott SJ, Gitlin SD, Bohan CA, Brady JN: Induction of nuclear NF-kB DNA binding activity after exposure of lymphoid cells to soluble Taxi protein. New Biol 1990, 2:1034-1043
48. Li-Weber M, Giaisi M, Chlichlia K, Khazaie K, Krammer PH: Human T cell leukemia virus type I Tax enhances IL-4 gene expression in T cells. Eur J Immunol 2001, 31:2623-2632
49. Cowan EP, Alexander RK, Daniel S, Kashanchi F, Brady JN: Induction of tumor necrosis factor alpha in human neuronal cells by extracellular human T cell lymphotropic virus type 1 Tax. J Virol 1997, 71:6982-6989
50. Alefantis T, Mostoller K, Jain P, Harhaj E, Grant C, Wigdahl B: Secretion of the human T cell leukemia virus type I transactivator protein tax. J Biol Chem 2005, 280:17353-17362
51. Tangy F, Vernant JC, Coscoy L, Ossondo M, Bellance R, Zaninovic V, Cartier L, Brahic M, Ozden S: A search for human T cell leukemia virus type I in the lesions of patients with tropical spastic paraparesis and polymyositis. Ann Neurol 1995, 38:454-460
52. Nerenberg MI, Wiley CA: Degeneration of oxidative muscle fibers in HTLV-1 tax transgenic mice. Am J Pathol 1989, 135:1025-1033
53. Wrzesinski S, Seguin R, Liu Y, Domville S, Flanelles V, Massa P, Barker E, Antel J, Feuer G: HTLV type 1 Tax transduction in microglial cells and astrocytes by lentiviral vectors. AIDS Res Hum Retroviruses 2000, 16:1771-1776
54. Reddy TR, Li X, Jones Y, Ellisman MH, Ching GY, Liem RK, Wong-Staal F: Specific interaction of HTLV tax protein and a human type IV neuronal intermediate filament protein. Proc Natl Acad Sci USA 1998, 95:702-707
55. Wu K, Bottazzi ME, de la Fuente C, Deng L, Gitlin SD, Maddukuri A, Dadgar S, Li H, Vertes A, Pumfery A, Kashanchi F: Protein profile of tax-associated complexes. J Biol Chem 2004, 279:495-508
56. Bornemann A, Schmalbruch H: Desmin and vimentin in regenerating muscles. Muscle Nerve 1992, 15:14-20
57. Vater R, Cullen MJ, Harris JB: The expression of vimentin in satellite cells of regenerating skeletal muscle in vivo. Histochem J 1994, 26:916-928
58. Lilienbaum A, Paulin D: Activation of the human vimentin gene by the Tax human T cell leukemia virus. I. Mechanisms of regulation by the NF-kappa B transcription factor. J Biol Chem 1993, 268:2180-2188
59. Winter A, Bornemann A: NCAM, vimentin and neonatal myosin heavy chain expression in human muscle diseases. Neuropathol Appl Neurobiol 1999, 25:417-424